TETRALOGY OF FALLOT (TOF)
Clinical trials for TETRALOGY OF FALLOT (TOF) explained in plain language.
Never miss a new study
Get alerted when new TETRALOGY OF FALLOT (TOF) trials appear
Sign up with your email to follow new studies for TETRALOGY OF FALLOT (TOF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart surgery in first month of life may give babies with rare defect a better future
Disease control Recruiting nowThis study tests whether operating within the first 28 days of life (neonatal repair) is safer and more effective than waiting until 3-6 months (infant repair) for babies born with Tetralogy of Fallot, a serious heart defect. About 160 full-term newborns weighing over 2.5 kg will…
Matched conditions: TETRALOGY OF FALLOT (TOF)
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated May 17, 2026 07:06 UTC
-
New registry tracks heart drug use in adults born with heart defects
Knowledge-focused Recruiting nowThis study is a global registry that will collect information from 400 adults with congenital heart disease who are taking a type of diabetes drug called SGLT2 inhibitors. The goal is to understand how these drugs are prescribed, how safe they are, and whether they help with hear…
Matched conditions: TETRALOGY OF FALLOT (TOF)
Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated May 12, 2026 13:39 UTC